Partnerships
Phi Pharma is currently optimising its lead and backup candidates for the initial oncology indications and is currently seeking financial and/or industrial partners to accelerate the preclinical development of these programmes beyond the achievement of in-vivo and ex-vivo proof of concept. Phi Pharma is also open to discussing how our targeting technology could benefit therapeutic assets held by potential partners.
For partnering inquiries, please contact [email protected].
For partnering inquiries, please contact [email protected].